Metabolon at ADPD 2026 – International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
Dates: March 17-21, 2026
Location: Copenhagen, Denmark
Visit the Official Event Website
Booth Location: 01C
Join Metabolon at ADPD 2026
Metabolon is attending ADPD 2026, the largest international event showcasing advances in Alzheimer’s, Parkinson’s, and related neurodegenerative diseases. This conference brings together leading neuroscientists, clinicians, and industry professionals to discuss breakthroughs in biomarker discovery, disease mechanisms, and therapeutic development.
Where to Find Metabolon at ADPD 2026
You can find Metabolon exhibiting at booth 01C, where several of the Metabolon team will be happy to demonstrate our metabolomics and bioinformatics solutions with you and discuss our experiences working in neurodegenerative disease research.
Scientific Themes and Program Highlights
- Theme A: β-Amyloid Diseases
- Theme B: Taupathies
- Theme C: α-Synucleinopathies
- Theme D: TDP43, TMEM106B and C9orf72-Related Diseases
- Theme E : Vascular Diseases
- Theme F: Prion Diseases
- Theme G: Huntington’s and Other Neurodegenerative Diseases
- Theme H: Demyelinating Diseases
- Theme I: Lysosomal Storage Diseases
- Theme J: Psychiatric Symptoms in Neurodegenerative Diseases
- Theme K: Patient Care and Support
- Theme L: COVID-19: Impact on Brain Neurodegenerative Diseases
Why Connect with Metabolon at ADPD 2026
Why Metabolon? | Metabolon
Metabolomics is transforming neuroscience research by offering deep, functional insights into brain biology, neurological conditions, and the complex metabolic signatures underlying neurodegenerative diseases. Metabolon’s proven metabolomics solutions help researchers accelerate discovery, uncover metabolic biomarkers, and advance therapeutic development with confidence.
With decades of scientific leadership and an unmatched metabolite reference library covering over 5,400 confidently annotated small molecules, Metabolon is the global expert in metabolomics. Our high-resolution mass-spectrometry platform delivers robust, quantitative metabolite data across species and sample types, supporting studies from foundational research through clinical translation.
Partnering with Metabolon gives you access to:
- Comprehensive metabolomics data generation, including both targeted and untargeted approaches.
- Seamless integration of metabolomics with other omics data to extract biological meaning and support multi-omics analyses.
- Actionable insights that advance biomarker discovery, drug development, and patient stratification in Alzheimer’s, Parkinson’s, ALS, and other neurological research areas.
- Data quality and reproducibility that propels rigorous research and enables translational impact.
Metabolon’s multi-omics driven approach is helping the neuroscience community push the boundaries of what’s possible in understanding and treating neurodegenerative disease.
Connect with us at Booth 01C or schedule a meeting via the form on this page to explore how our solutions can support your research.
